The ProtecT trial: analysis of the patient cohort, baseline risk stratification and disease progression

OBJECTIVE: To test the hypothesis that the baseline clinico‐pathological features of the men with localized prostate cancer (PCa) included in the ProtecT (Prostate Testing for Cancer and Treatment) trial who progressed (n = 198) at a 10‐year median follow‐up were different from those of men with sta...

Descripción completa

Detalles Bibliográficos
Autores principales: Bryant, Richard J., Oxley, Jon, Young, Grace J., Lane, Janet A., Metcalfe, Chris, Davis, Michael, Turner, Emma L., Martin, Richard M., Goepel, John R., Varma, Murali, Griffiths, David F., Grigor, Ken, Mayer, Nick, Warren, Anne Y., Bhattarai, Selina, Dormer, John, Mason, Malcolm, Staffurth, John, Walsh, Eleanor, Rosario, Derek J., Catto, James W.F., Neal, David E., Donovan, Jenny L., Hamdy, Freddie C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Trial
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7187290/
https://www.ncbi.nlm.nih.gov/pubmed/31900963
http://dx.doi.org/10.1111/bju.14987

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7187290/
https://www.ncbi.nlm.nih.gov/pubmed/31900963
http://dx.doi.org/10.1111/bju.14987

Ejemplares similares